Healthequity Stock Technical Analysis
| HQY Stock | USD 81.42 1.55 1.94% |
As of the 18th of April 2024, HealthEquity retains the risk adjusted performance of 0.0281, and Market Risk Adjusted Performance of 0.1193. HealthEquity technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to break down and collect data for nineteen technical drivers for HealthEquity, which can be compared to its competitors. Please check out HealthEquity standard deviation, as well as the relationship between the value at risk and kurtosis to decide if HealthEquity is priced fairly, providing market reflects its last-minute price of 81.42 per share. Given that HealthEquity has jensen alpha of 0.0304, we strongly advise you to confirm HealthEquity's regular market performance to make sure the company can sustain itself at a future point.
HealthEquity Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as HealthEquity, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to HealthEquityHealthEquity |
HealthEquity Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 85.9 | Strong Buy | 14 | Odds |
Most HealthEquity analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand HealthEquity stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of HealthEquity, talking to its executives and customers, or listening to HealthEquity conference calls.
HealthEquity technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
HealthEquity Technical Analysis
The output start index for this execution was two hundred with a total number of output elements of one hundred ninety-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of HealthEquity volatility. High ATR values indicate high volatility, and low values indicate low volatility.
HealthEquity Trend Analysis
Use this graph to draw trend lines for HealthEquity. You can use it to identify possible trend reversals for HealthEquity as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual HealthEquity price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.HealthEquity Best Fit Change Line
The following chart estimates an ordinary least squares regression model for HealthEquity applied against its price change over selected period. The best fit line has a slop of 0.04 , which may imply that HealthEquity will maintain its good market sentiment and make money for investors. It has 782 observation points and a regression sum of squares at 17495.2, which is the sum of squared deviations for the predicted HealthEquity price change compared to its average price change.About HealthEquity Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of HealthEquity on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of HealthEquity based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on HealthEquity price pattern first instead of the macroeconomic environment surrounding HealthEquity. By analyzing HealthEquity's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of HealthEquity's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to HealthEquity specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 (projected) | Dividend Yield | 0.07 | 0.0735 | Price To Sales Ratio | 6.47 | 6.57 |
HealthEquity April 18, 2024 Technical Indicators
Most technical analysis of HealthEquity help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for HealthEquity from various momentum indicators to cycle indicators. When you analyze HealthEquity charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0281 | |||
| Market Risk Adjusted Performance | 0.1193 | |||
| Mean Deviation | 1.68 | |||
| Semi Deviation | 2.38 | |||
| Downside Deviation | 2.43 | |||
| Coefficient Of Variation | 4121.77 | |||
| Standard Deviation | 2.4 | |||
| Variance | 5.78 | |||
| Information Ratio | 0.0032 | |||
| Jensen Alpha | 0.0304 | |||
| Total Risk Alpha | (0.06) | |||
| Sortino Ratio | 0.0032 | |||
| Treynor Ratio | 0.1093 | |||
| Maximum Drawdown | 20.29 | |||
| Value At Risk | (3.49) | |||
| Potential Upside | 3.54 | |||
| Downside Variance | 5.92 | |||
| Semi Variance | 5.65 | |||
| Expected Short fall | (1.74) | |||
| Skewness | (0.44) | |||
| Kurtosis | 6.71 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HealthEquity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index. For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for HealthEquity Stock analysis
When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
Is HealthEquity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HealthEquity. If investors know HealthEquity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HealthEquity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.96) | Earnings Share 0.64 | Revenue Per Share 11.682 | Quarterly Revenue Growth 0.122 | Return On Assets 0.0256 |
The market value of HealthEquity is measured differently than its book value, which is the value of HealthEquity that is recorded on the company's balance sheet. Investors also form their own opinion of HealthEquity's value that differs from its market value or its book value, called intrinsic value, which is HealthEquity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HealthEquity's market value can be influenced by many factors that don't directly affect HealthEquity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HealthEquity's value and its price as these two are different measures arrived at by different means. Investors typically determine if HealthEquity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HealthEquity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.